Substantial improvements in ultrasound technology and expanded use of it have necessitated an update of the 2012 ...

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune cells attacking the joints and can result in pain, swelling, and damage to ...

Augurex Life Sciences, Quest Diagnostics collaborate to improve rheumatoid arthritis diagnosis and management: Vancouver, Canada Monday, November 18, 2024, 16:00 Hrs [IST] Augurex ...

Findings indicate gut microbiome diversity changes precede rheumatoid arthritis, offering insights into microbial indicators ...

For this study, researchers recruited 124 people at risk of developing rheumatoid arthritis, seven people who had recently ...

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...

Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical ...

The 14-3-3eta test aids in detecting elevated levels of the 14-3-3eta protein, which are specific for rheumatoid arthritis (RA) and linked to more severe disease and joint damage risk.